These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 14618553

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM.
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia.
    Breier A, Hamilton SH.
    Biol Psychiatry; 1999 Feb 15; 45(4):403-11. PubMed ID: 10071708
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM.
    J Clin Psychiatry; 1997 May 15; 58(5):205-11. PubMed ID: 9184614
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
    Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.
    Clin Ther; 2003 May 15; 25(5):1420-8. PubMed ID: 12867218
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
    Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, Lawson WB, Emsley RA, Zhang F, Baker RW, Risser RC, Namjoshi MA, Evans AR, Breier A.
    Arch Gen Psychiatry; 2003 Dec 15; 60(12):1218-26. PubMed ID: 14662554
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
    Ishigooka J, Inada T, Miura S.
    Psychiatry Clin Neurosci; 2001 Aug 15; 55(4):403-14. PubMed ID: 11442893
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.
    Arch Gen Psychiatry; 2002 May 15; 59(5):441-8. PubMed ID: 11982448
    [Abstract] [Full Text] [Related]

  • 20. A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial.
    Berk M, Brook S, Trandafir AI.
    Int Clin Psychopharmacol; 1999 May 15; 14(3):177-80. PubMed ID: 10435771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.